Follow-The-Filings

CTOR Citius Oncology

Citius Oncology earnings company data as of 7:18 PM ET 8/21

  • 0 of 1 EPS beats

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q3 14 Aug EPS -0.07 -0.08 Miss
Rev $1.5M

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q QUARTERLY REPORT
424B3 PROSPECTUS
8-K 5.02,9.01
8-K 8.01,9.01
424B3 PROSPECTUS SUPPLEMENT
8-K 8.01,9.01
424B3
424B3 PROSPECTUS SUPPLEMENT
10-Q QUARTERLY REPORT
8-K 2.02,9.01
8-K 1.01,2.03,3.02,8.01,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
8-K 8.01,9.01
8-K 3.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
10-Q QUARTERLY REPORT
8-K 2.02,9.01
10-K ANNUAL REPORT
8-K 2.02,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,3.02,8.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 1 row shown

Filed Form Detail Links
4/A Period Sep 19, 2025 · 5 forms

9 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice